Mechanisms involve the activation of alternative signaling pathways, such as the CARM1‐TRIM47‐SNAI1 axis, where the stabilization of TRIM47 promotes EMT and metastasis, providing a route for HCC to evade treatment [99]. Here, TRIM47 is linked to hepatocellular carcinoma.